Ultrasound Guided Hematoma Block in Distal Radius Fractures
1 other identifier
interventional
40
1 country
1
Brief Summary
This study will investigate the effectiveness of analgesia of ultrasound hematoma block compared to 'blind' hematoma block in patients with dislocated distal radius fracture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2023
CompletedFirst Posted
Study publicly available on registry
January 5, 2024
CompletedStudy Start
First participant enrolled
January 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMarch 19, 2024
March 1, 2024
11 months
September 21, 2023
March 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effectiveness of analgesia during closed reduction of a distal radius fracture
Pain reduction will be measured on a Numeric Rating Scale( NRS-scale; 0-10) at different moments
NRS before, during and after (10-15 min) injection of hematoma block, NRS-score during closed reduction and after closed reduction (5 min)
Secondary Outcomes (11)
Number of participants in which hematoma was aspirated during hematoma block
During hematoma block
Procedural time of the Hematoma block
Time from insertion of the needle until needle is withdrawn out of the patient (up to maximum of 30 min.)
Procedural time of the reduction
From moment physician is ready to start the reduction until cast is applied (up to maximum of 30 min.)
Satisfaction of the HB provided by physician performing the HB procedure
10-15 minutes after hematoma block
Satisfaction of reduction provided by physician performing reduction measured
10-15 minutes after closed reduction
- +6 more secondary outcomes
Study Arms (2)
Ultrasound guided hematoma block
EXPERIMENTALPatients in this group will receive ultrasound guided hematoma block before reduction of their dislocated distal radius fracture.
Blind hematoma block
ACTIVE COMPARATORPatients in this group will receive standard treatment; hematoma block with palpation of the fracture site (blind hematoma block)
Interventions
Patients with a dislocated fracture of the distal radius will receive ultrasound guided hematoma block with 10mL lidocaine 2% to get real-time guidance of the given anesthesia into the fracture site before closed reduction of a distal radius fracture.
Patients with a distal radius fracture will receive standard treatment; hematoma block with 10mL 2% lidocaine performed with palpation of the fracture site (blind hematoma block) before closed reduction of dislocated distal radius fractures.
Eligibility Criteria
You may qualify if:
- Age ≥ 16 years
- Confirmed fracture of the distal radius requiring closed reduction, defined as any off the following items(7):
- \>10 degrees of dorsal angulation;
- \>20 degrees of volar angulation;
- \>2 mm step-off intra-articular;
- \>3 mm radial shortening;
- \>15 degrees radial inclination;
- Translation and non-intact radio-carpal alignment in the lateral view
- Significant translation in the posterior-anterior(PA)-view.
You may not qualify if:
- No informed consent can be given (cognitive impairment, severe dementia, no knowledge of Dutch language e.a.)
- Neurovascular compromise or open fractures requiring (immediate) surgery or reduction.
- First reduction already performed
- Multi-trauma patients requiring other urgent procedures/tests or with respiratory or hemodynamical compromise
- Pre-existent osteosynthesis material in situ in the affected arm
- Skin injury (with exception of minor abrasions), local infection or recent burns hindering or contra-indicating the use of ultrasound and ultrasound gel
- Allergy for local anesthetics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medisch Centrum Leeuwarden
Leeuwarden, Provincie Friesland, 8934AD, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pieter Veenstra
Medisch Centrum Leeuwarden
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Because treatment in both groups are different (one group with and one group without ultrasound) it's not possible to mask the treating physician for the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 21, 2023
First Posted
January 5, 2024
Study Start
January 5, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2024
Last Updated
March 19, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share